Humacyte Stock

humacyte.comHealthcare / BioTech & PharmaFounded: 2004Funding to Date: $440MM

Humacyte is the developer of a biotechnology platform designed to deliver universally implantable bioengineered human tissues and organs designed to improve the lives of patients and transform the practice of medicine.

Register To Buy and Sell Shares

For more details on financing and valuation for Humacyte, register or login.

Please provide a valid email address.

By registering, you agree to Forge’s Terms of Use. Already registered? Log in


Enterprise Value

Powered by Forge Data

Access Humacyte’s valuation and stock price.

View secondary pricing information, VWAP and distribution waterfall. And seek potentially outsized returns with same day private market data for private companies like Humacyte.

Become part of the Secondary Marketplace, catering to both individual and institutional investors.


Animation displayed is not current and securities are shown for illustrative purposes only.


Management Team

Theodore Lithgow Ph.D
Chief Operating Officer
William Tente
Chief Regulatory Officer
Shannon Dahl Ph.D
Jeffrey Lawson MD
President & Chief Executive Officer
Carrie Cox
Chairman & Chief Executive Officer
Laura Niklason MD
Co-Founder & Board Member
Jack Harvey
Vice President, Bioprocessing
Douglas Blankenship
Chief Financial Officer
Juliana Blum Ph.D
Co-Founder & Vice President, Business Operations & Tissue Services
Heather Prichard Ph.D
Senior Vice President of Product Development

Board Members

Brady Dougan
Credit Suisse
Laura Niklason MD
Carrie Cox
Max Wallace JD
Dale Sander
Kathleen Sebelius
Robert Anderson MD
Robert Langer Ph.D

Humacyte’s stock FAQs


Can you buy Humacyte’s stock?

Humacyte is not publicly traded on NYSE or NASDAQ in the U.S. To buy Humacyte’s stock you need to be an accredited investor. Learn more about how to invest in the private market or register today to get started.

Can you sell Humacyte’s stock?

Yes, you can sell stock of a private company like Humacyte. Forge can help you sell your Humacyte stock in a way that works for you and the company. So if you are seeking liquidity, register with us today to get started.

What is Humacyte’s stock price?

Humacyte is a privately held company and therefore does not have a public stock price. However, you may access Humacyte’s private market stock price with Forge Data.

What is Humacyte’s stock ticker symbol?

Humacyte does not have an official ticker symbol because this company is not currently publicly traded.

Can institutional investors buy and sell private market stocks?

Yes. As one of the largest trading platform for the private market, Forge helps institutional investors seek liquidity as they buy and sell private stock for their portfolios or their clients. Our private market specialists have decades of experience working with institutional firms. Learn more or register today to get started.
Updated on: Jun 21, 2024


Public news articles listed on this page have been curated by Forge based on several factors including, but not limited to, product updates, changes in organization structure, funding rounds, third-party valuations, and key personnel changes. Changes to this list of articles can be made at any time without notice and should not be relied upon for investment purposes. Forge does not verify the accuracy of the information contained in public news articles.